Search Results - Devi SenGupta

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod by Mohamed Abdel-Mohsen, Steven Deeks, Leila Giron, Kai Ying Hong, Aaron Goldman, Liao Zhang, Susie S. Y. Huang, Donovan Verrill, Susan Guo, Lisa Selzer, Christiaan R. de Vries, Elena Vendrame, Devi SenGupta, Jeffrey J. Wallin, Yanhui Cai

    Published in Frontiers in Immunology (2024-06-01)
    Get full text
    Article


  2. 2

    The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV by Yanan Zheng, Mary Wire, Robert Were Omange, Christiaan R. deVries, Liao Zhang, Buyun Chen, Susie S. Y. Huang, Kimberly Cruz, Howard Hassman, Olayemi Osiyemi, Juan Carlos Rondon, Daina Lim, Steve West, Anita Wen, Jeffrey J. Wallin, Devi SenGupta, Yanhui Cai

    Published in Infectious Diseases and Therapy (2025-09-01)
    Get full text
    Article


  3. 3

    A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod by Sharon A. Riddler, Constance A. Benson, Cynthia Brinson, Steven G. Deeks, Edwin DeJesus, Anthony Mills, Michael F. Para, Moti N. Ramgopal, Yanhui Cai, Yanan Zheng, Liao Zhang, Wendy Jiang, Xiaopeng Liu, Donovan Verrill, Daina Lim, Christiaan R. de Vries, Jeffrey J. Wallin, Elena Vendrame, Devi SenGupta

    Published in Infectious Diseases and Therapy (2024-09-01)
    Get full text
    Article


  4. 4

    Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective... by Jesper D. Gunst, Jesal Gohil, Johanthan Z. Li, Ronald J. Bosch, Andrea White, Catherine Seamon, Tae-Wook Chun, Beatriz Mothe, Kathleen Gittens, Lauren Praiss, Marie-Angélique De Scheerder, Linos Vandekerckhove, Kevin Escandón, Ann Thorkelson, Timothy Schacker, Devi SenGupta, Christian Brander, Emmanouil Papasavvas, Luis J. Montaner, Javier Martinez-Picado, Ruxandra Calin, Antonella Castagna, Camilla Muccini, Wesley de Jong, Lorna Leal, Felipe Garcia, Rob A. Gruters, Timothy Tipoe, John Frater, Ole S. Søgaard, Sarah Fidler

    Published in Nature Communications (2025-01-01)
    Get full text
    Article


  5. 5

    Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial by Lucia Bailón, José Moltó, Adrian Curran, Julen Cadiñanos, Juan Carlos Lopez Bernaldo de Quirós, Ignacio de Los Santos, Juan Ambrosioni, Arkaitz Imaz, Susana Benet, Paula Suanzes, Jordi Navarro, Juan González-García, Carmen Busca, Leire Pérez-Latorre, Juan Berenguer, Lucio Jesús García-Fraile, Gina Mejía-Abril, Jose M. Miró, Sofía Scévola, Santiago Moreno, Pere Domingo, Yuan Tian, Michelle Frankot, Daina Lim, Yanhui Cai, Elena Vendrame, Susan Guo, Jeffrey J. Wallin, Romas Geleziunas, Devi SenGupta, Yovaninna Alarcón-Soto, Isabel Leal, Alvaro Aranguen, Margarida Garcia-Garcia, Ian McGowan, Christian Brander, Jose Ramón Arribas, Beatriz Mothe, On behalf of the AELIX-003 Study Group

    Published in Nature Communications (2025-03-01)
    Get full text
    Article


Search Tools: